The Chroma Group (Chroma) is a software company that develops complex analytical applications for life and earth sciences, using advanced technology for pattern recognition and complex systems simulation. Chroma is funded by Draper Fisher Jurvetson and TDI. The Board includes Tim Draper, Bill O’Connell (Vice Chairman and Co-founder of Amdahl) and Kevin J. Ryan.

Chroma’s Chief Scientist, Dr. Fredric Young, is a theoretical biophysicist, former NIH researcher, early Genentech employee, and inventor of several patented, breakthrough technologies, including ImageGenetics®, a biomathematical pattern recognition technology. Chroma builds applications based on Dr. Young’s inventions and then hires
teams and funds the companies separately.

To date, the Chroma Group has focused on life and earth sciences and launched the following three companies:

• Quantitative Imaging, a medical device company that develops computer-aided detection (CAD) software for major medical imaging screening indications using biomathematical pattern recognition technology.


• Chroma Energy, an energy company that discovers and develops natural gas deposits worldwide using biomathematical pattern recognition technology.

• Vicus Therapeutics (Vicus), a biopharmaceutical company developing supportive care therapies to improve the survival and the quality of life of cancer patients. Vicus is creating high value, safe, and effective therapies with substantially reduced regulatory and commercial risks, costs, and timetables.